2025 annual financial data
Propanc Biopharma, Inc. 2025 Operating margin
Propanc Biopharma, Inc. 2025 operating margin with verified reported values.
Direct answer
Operating margin was Not calculable.
Operating income was -57,278,131 USD and net income was -58,923,300 USD.
Operating cash flow was -405,168 USD.
Get free Propanc Biopharma, Inc. email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 USD
- Operating income
- -57,278,131 USD
- Net income
- -58,923,300 USD
- Operating cash flow
- -405,168 USD